What is it about?
Preclinical study to evaluate the efficacy of Mesenchymal StemCells (MSCs) derived exosomes in the treatment of synovitis
Featured Image
Why is it important?
The subcutaneous and intraarticular BSA immunization repro-duces, at least in part, the inflammatory events that normallyoccur in synovitis. Finally, according to our results, MSCs-derivedexosomes could represent an alternative to others conventionaltherapies in the treatment of synovitis.
Read the Original
This page is a summary of: Mesenchymal stem cell derived exosomes in the treatment of synovitis: proof of concept in large animal model, New Biotechnology, May 2016, Elsevier,
DOI: 10.1016/j.nbt.2015.10.064.
You can read the full text:
Resources
Mesenchymal stem cell derived exosomes in the treatment of synovitis: proof of concept in large animal model
https://www.sciencedirect.com/science/article/abs/pii/S1871678415002332?via%3Dihub
Mesenchymal stem cell derived exosomes in the treatment of synovitis: proof of concept in large animal model
https://www.researchgate.net/publication/298432984_Mesenchymal_stem_cell_derived_exosomes_in_the_treatment_of_synovitis_proof_of_concept_in_large_animal_model
Contributors
The following have contributed to this page
